Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer [Yahoo! Finance]
Allurion Technologies, Inc. (ALUR)
Company Research
Source: Yahoo! Finance
Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas assumed the role of Chief Operating Officer and will lead the company's Research and Development, Manufacturing and Operations, Quality and Regulatory, and Business Development and Innovation functions. He will also play a crucial role in commercial functions while working closely with the Board and Executive Leadership Team. Ojas will provide strategic and execution-focused guidance aimed to help the company achieve major milestones and scale sustainably. With a 25-year track record in the healthcare industry, Ojas is a seasoned executive known for his strategic mindset and adaptable tactics. He brings extensive cross-functional expertise and global experience, having led integrated and matrix organizations at GE Healthcare, St Jude Medical (Abbott), CareFusion (Vyaire), Philips and most recently as President, PENTAX Medical – Americas where he drove transformation with a focus on compliance and customer-centri
Show less
Read more
Impact Snapshot
Event Time:
ALUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALUR alerts
High impacting Allurion Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
ALUR
News
- Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst [Seeking Alpha]Seeking Alpha
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss [Yahoo! Finance]Yahoo! Finance
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight LossBusiness Wire
- Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy [Yahoo! Finance]Yahoo! Finance
- Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]Yahoo! Finance
ALUR
Earnings
- 3/21/24 - Beat
ALUR
Sec Filings
- 6/26/24 - Form S-1
- 6/26/24 - Form 8-K
- 6/21/24 - Form POS
- ALUR's page on the SEC website